Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Goserelin|DRUG: Tamoxifen|DRUG: Aromatase Inhibitors|DRUG: Leuprolide
Sponsor: First Affiliated Hospital, Sun Yat-Sen University